153 related articles for article (PubMed ID: 15584523)
1. Photobleaching kinetics of Photofrin in vivo and in multicell tumour spheroids indicate two simultaneous bleaching mechanisms.
Finlay JC; Mitra S; Patterson MS; Foster TH
Phys Med Biol; 2004 Nov; 49(21):4837-60. PubMed ID: 15584523
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro.
Dysart JS; Patterson MS
Phys Med Biol; 2005 Jun; 50(11):2597-616. PubMed ID: 15901957
[TBL] [Abstract][Full Text] [Related]
3. Photobleaching kinetics, photoproduct formation, and dose estimation during ALA induced PpIX PDT of MLL cells under well oxygenated and hypoxic conditions.
Dysart JS; Patterson MS
Photochem Photobiol Sci; 2006 Jan; 5(1):73-81. PubMed ID: 16395430
[TBL] [Abstract][Full Text] [Related]
4. The mechanism of Photofrin photobleaching and its consequences for photodynamic dosimetry.
Georgakoudi I; Nichols MG; Foster TH
Photochem Photobiol; 1997 Jan; 65(1):135-44. PubMed ID: 9066293
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy using Photofrin in combination with buthionine sulfoximine (BSO) to treat 9L gliosarcoma in rat brain.
Jiang F; Lilge L; Belcuig M; Singh G; Grenier J; Li Y; Chopp M
Lasers Surg Med; 1998; 23(3):161-6. PubMed ID: 9779650
[TBL] [Abstract][Full Text] [Related]
6. Modeling of a type II photofrin-mediated photodynamic therapy process in a heterogeneous tissue phantom.
Hu XH; Feng Y; Lu JQ; Allison RR; Cuenca RE; Downie GH; Sibata CH
Photochem Photobiol; 2005; 81(6):1460-8. PubMed ID: 15960591
[TBL] [Abstract][Full Text] [Related]
7. Photophysical parameters, photosensitizer retention and tissue optical properties completely account for the higher photodynamic efficacy of meso-tetra-hydroxyphenyl-chlorin vs Photofrin.
Mitra S; Foster TH
Photochem Photobiol; 2005; 81(4):849-59. PubMed ID: 15807635
[TBL] [Abstract][Full Text] [Related]
8. [Selective hematoporphyrin derivative (HMD) application in arterial vessels using a porous balloon catheter results in equivalent levels as compared to high-dose systemic administration].
Gonschior P; Erdemci A; Gerheuser F; Gonschior GM; Mack B; Kolbe T; Goetz AE; Höfling B
Z Kardiol; 1991 Dec; 80(12):738-45. PubMed ID: 1837968
[TBL] [Abstract][Full Text] [Related]
9. Singlet oxygen- versus nonsinglet oxygen-mediated mechanisms of sensitizer photobleaching and their effects on photodynamic dosimetry.
Georgakoudi I; Foster TH
Photochem Photobiol; 1998 Jun; 67(6):612-25. PubMed ID: 9648527
[TBL] [Abstract][Full Text] [Related]
10. Quantum yields and kinetics of the photobleaching of hematoporphyrin, Photofrin II, tetra(4-sulfonatophenyl)-porphine and uroporphyrin.
Spikes JD
Photochem Photobiol; 1992 Jun; 55(6):797-808. PubMed ID: 1409888
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy of U87 human glioma in nude rat using liposome-delivered photofrin.
Jiang F; Lilge L; Grenier J; Li Y; Wilson MD; Chopp M
Lasers Surg Med; 1998; 22(2):74-80. PubMed ID: 9484699
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy with photofrin reduces invasiveness of malignant human glioma cells.
Jiang F; Chopp M; Katakowski M; Cho KK; Yang X; Hochbaum N; Tong L; Mikkelsen T
Lasers Med Sci; 2002; 17(4):280-8. PubMed ID: 12417983
[TBL] [Abstract][Full Text] [Related]
13. A preliminary pharmacokinetic study of intravenous Photofrin in patients.
Bellnier DA; Dougherty TJ
J Clin Laser Med Surg; 1996 Oct; 14(5):311-4. PubMed ID: 9612197
[TBL] [Abstract][Full Text] [Related]
14. Quantification of in vivo Photofrin uptake by human pituitary adenoma tissue.
Igbaseimokumo U
J Neurosurg; 2004 Aug; 101(2):272-7. PubMed ID: 15309918
[TBL] [Abstract][Full Text] [Related]
15. Photofrin as a radiosensitizer in an in vitro cell survival assay.
Kulka U; Schaffer M; Siefert A; Schaffer PM; Olsner A; Kasseb K; Hofstetter A; Dühmke E; Jori G
Biochem Biophys Res Commun; 2003 Nov; 311(1):98-103. PubMed ID: 14575700
[TBL] [Abstract][Full Text] [Related]
16. Intraperitoneal photodynamic therapy in the rat: comparison of toxicity profiles for photofrin and MTHPC.
Veenhuizen RB; Ruevekamp-Helmers MC; Helmerhorst TJ; Kenemans P; Mooi WJ; Marijnissen JP; Stewart FA
Int J Cancer; 1994 Dec; 59(6):830-6. PubMed ID: 7989125
[TBL] [Abstract][Full Text] [Related]
17. Increased efficacy of photodynamic therapy of R3230AC mammary adenocarcinoma by intratumoral injection of Photofrin II.
Gibson SL; van der Meid KR; Murant RS; Hilf R
Br J Cancer; 1990 Apr; 61(4):553-7. PubMed ID: 2139578
[TBL] [Abstract][Full Text] [Related]
18. The effect of photodynamic therapy on a retinoblastoma-like tumour. An experimental in vitro and in vivo study on the potential use of photodynamic therapy in the treatment of retinoblastoma.
Winther JB
Acta Ophthalmol Suppl (1985); 1990; (197):1-37. PubMed ID: 2176429
[TBL] [Abstract][Full Text] [Related]
19. In vivo mTHPC photobleaching in normal rat skin exhibits unique irradiance-dependent features.
Finlay JC; Mitra S; Foster TH
Photochem Photobiol; 2002 Mar; 75(3):282-8. PubMed ID: 11950094
[TBL] [Abstract][Full Text] [Related]
20. Photofrin accumulation in malignant and host cell populations of various tumours.
Korbelik M; Krosl G
Br J Cancer; 1996 Feb; 73(4):506-13. PubMed ID: 8595166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
